Floatz logo

azd6244

Colon Neoplasms

AstraZenecaPhase 2Dormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Colon Neoplasms cohort.

Asset / SponsorPhaseRating
Temsirolimus
Vejle Hospital
Phase 2B
DACARBAZINE
AstraZeneca
Phase 1CC
gi-6301
ImmunityBio, Inc.
Phase 1/2C

Same molecule, other indications

azd6244 is also rated in:

Stage IV Pancreatic CancerDormant
BB
Indicative ·
70 / 100
View asset →
malignant pancreatic neoplasmDormant
BB
Indicative ·
67 / 100
View asset →
uveal melanomaDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →